Physician profile
Prema Modak
NPI 1689894578
$1,038.83
in general payments reported to CMS, 2019-2025
12 companies · $60.67 in 2025
The $60.67 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $110 · 2021: $340 · 2022: $277 · 2023: $44.24 · 2024: $207 · 2025: $60.67.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $312.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $311.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $578.28 | 2019-2022 | |
| New World Medical,INC. | $114.24 | 2022 | |
| Tarsus Pharmaceuticals, INC. | $57.76 | 2024-2025 | Xdemvy |
| Oyster Point Pharma, INC. | $55.18 | 2024-2025 | Tyrvaya |
| Bausch & Lomb Americas INC. | $51.28 | 2024 | Miebo, Xiidra |
| Glaukos Corporation | $44.24 | 2023 | Kxl1b-Ce-Marked Kxlsystem, Kxl System (Refurbished) |
| Rxsight INC | $31.24 | 2024 | Light Adjustable Lens (Lal), Rxsight Contact Lens, Rxsight Injector Handpiece |
| Sun Pharmaceutical Industries INC. | $27.01 | 2024 | |
| Thea Pharma INC. | $24.99 | 2024 | Iyuzeh |
| Biotissue Holdings INC. | $19.97 | 2024 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $17.34 | 2019 | |
| Aerie Pharmaceuticals, INC. | $17.30 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Prema Modak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.